Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05483400
Title Open Label Phase 2 Basket Trial With Atezolizumab and Tiragolumab in Solid Tumors (TIRACAN)
Acronym TIRACAN
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University Medical Center Groningen
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD


No variant requirements are available.